ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,118,076 | -17.3% | 1,745,943 | 0.0% | 5.10% | +9.6% |
Q2 2023 | $23,116,285 | -2.7% | 1,745,943 | 0.0% | 4.66% | -24.6% |
Q1 2023 | $23,762,284 | -30.3% | 1,745,943 | 0.0% | 6.17% | -30.2% |
Q4 2022 | $34,098,267 | +2.5% | 1,745,943 | 0.0% | 8.85% | +12.3% |
Q3 2022 | $33,260,000 | -7.5% | 1,745,943 | 0.0% | 7.88% | -21.2% |
Q2 2022 | $35,966,000 | -36.0% | 1,745,943 | 0.0% | 9.99% | -33.7% |
Q1 2022 | $56,184,000 | -34.6% | 1,745,943 | -5.4% | 15.08% | -3.7% |
Q4 2021 | $85,890,000 | +51.0% | 1,844,727 | -12.5% | 15.66% | +77.4% |
Q3 2021 | $56,891,000 | -5.2% | 2,107,092 | -9.9% | 8.82% | -10.4% |
Q2 2021 | $59,985,000 | -25.5% | 2,338,581 | -0.7% | 9.85% | -2.6% |
Q1 2021 | $80,513,000 | -49.5% | 2,355,557 | -50.0% | 10.12% | -26.5% |
Q4 2020 | $159,330,000 | +174.2% | 4,711,114 | +100.0% | 13.76% | -1.7% |
Q3 2020 | $58,112,000 | – | 2,355,557 | – | 14.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |